| 000 | 01630 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513141608.0 | ||
| 264 | 0 | _c19980429 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a1083-7450 | ||
| 024 | 7 |
_a10.3109/10837459709022620 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCiftci, K | |
| 245 | 0 | 0 |
_aSolid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres. _h[electronic resource] |
| 260 |
_bPharmaceutical development and technology _cMay 1997 |
||
| 300 |
_a151-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacokinetics |
| 650 | 0 | 4 | _aBiodegradation, Environmental |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLactic Acid |
| 650 | 0 | 4 |
_aLiver Neoplasms, Experimental _xdrug therapy |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 | _aMolecular Weight |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPolyesters |
| 650 | 0 | 4 | _aPolymers |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aTechnetium |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 | _aViscosity |
| 700 | 1 | _aHincal, A A | |
| 700 | 1 | _aKas, H S | |
| 700 | 1 | _aErcan, T M | |
| 700 | 1 | _aSungur, A | |
| 700 | 1 | _aGuven, O | |
| 700 | 1 | _aRuacan, S | |
| 773 | 0 |
_tPharmaceutical development and technology _gvol. 2 _gno. 2 _gp. 151-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10837459709022620 _zAvailable from publisher's website |
| 999 |
_c9519805 _d9519805 |
||